Neogen Stock Gains Following Strategic Alliance With Syngenta

Company Developments - Neogen Corporation (NEOG) has entered into a strategic licensing and supply agreement with Syngenta, granting exclusive rights to market and sell Talon-G and Talon Weatherblok XT rodenticides in the United States and Canada, which is expected to enhance Neogen's rodenticide portfolio with established products [1][5] - Following the announcement, NEOG shares increased by 4.7% to $6.70 in after-market trading [2] - Neogen's market capitalization stands at $1.43 billion, with an earnings yield of 5.75%, significantly higher than the industry's 0.04% [4] - The Zacks Consensus Estimate for fiscal 2026 earnings is projected at 44 cents per share, indicating a growth of 17.1% from fiscal 2025 [4] Industry Insights - The global rodenticides market was valued at $6.34 billion in 2024 and is anticipated to reach $8.64 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3% [7] - The rodenticides market is crucial for pest control, addressing challenges posed by rodent-borne diseases and crop damage [7] Product Innovations - Neogen launched the Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96), which improves sensitivity and accuracy in pathogen testing [8] - In late 2024, Neogen introduced the Petrifilm Bacillus cereus Count Plate, providing a reliable testing method for food safety professionals [9]